CN Patent

CN1278175A — 降脂剂的组合物

Assigned to Janssen Pharmaceutica NV · Expires 2000-12-27 · 25y expired

What this patent protects

本发明有关新颖的降脂剂的组合物,其可用于患高血脂症、肥胖症或动脉硬化症的哺乳动物,其中可一天给予一次单一此等剂型,并可由该哺乳动物在一天中任何时间服药,不受进食情形影响。此等新颖组合物包含由降脂剂及适当的水溶性聚合物的混合物熔融挤压,随后碾磨该熔融挤压的混合物而形成的颗粒。

USPTO Abstract

本发明有关新颖的降脂剂的组合物,其可用于患高血脂症、肥胖症或动脉硬化症的哺乳动物,其中可一天给予一次单一此等剂型,并可由该哺乳动物在一天中任何时间服药,不受进食情形影响。此等新颖组合物包含由降脂剂及适当的水溶性聚合物的混合物熔融挤压,随后碾磨该熔融挤压的混合物而形成的颗粒。

Drugs covered by this patent

Patent Metadata

Patent number
CN1278175A
Jurisdiction
CN
Classification
—
Expires
2000-12-27
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.